Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Alumis is an innovative biopharmaceutical company based in the US, specializing in the development of precision medicine therapies. By leveraging advanced technology, Alumis researches targeted treatment methods designed to address the underlying causes of complex immunological diseases.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Alumis is scheduled to report its next quarterly earnings on 11/12/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Alumis last reported quarterly earnings on 8/19/2026 (Q2 2026). Earnings per share (EPS) came in at -1.11 USD.
Across its last 3 earnings reports, Alumis stock moved by ±4.4% on average the following day. The largest reaction was -7.2% on 05/14/2026; 0 of 3 reactions were positive.
Alumis has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.